Programmed death ligand-1, tumor infiltrating lymphocytes and HLA expression in Chinese extrahepatic cholangiocarcinoma patients: Possible immunotherapy implications-Reference-Cited by-同舟云学术

Programmed death ligand-1, tumor infiltrating lymphocytes and HLA expression in Chinese extrahepatic cholangiocarcinoma patients: Possible immunotherapy implications

Published:2019-02-28 Issue:1 Volume:13 Page:58-69
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Yu Fei¹,Gong Lei²,Mo Zheng³,Wang Wenran¹²,Wu Meilong¹²,Yang Jianghui⁴,Zhang Qiongqiong¹,Li Li⁴,Yao Jingjing⁴,Dong Jiahong¹

Affiliation:

1. School of Clinical Medicine, Tsinghua University

2. Department of Hepatopancreatobiliary Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University

3. Department of Hematology and Oncology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University

4. Department of Pathology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine,Health (social science)

Link

https://www.jstage.jst.go.jp/article/bst/13/1/13_2019.01003/_pdf

Reference49 articles.

1. 1. Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014; 383:2168-2179.

2. 2. Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford). 2008; 10:77-82.

3. 3. Khan SA, Emadossadaty S, Ladep NG, Thomas HC, Elliott P, Taylor-Robinson SD, Toledano MB. Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us? J Hepatol. 2012; 56:848-854.

4. 4. DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD. Cholangiocarcinoma: Thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007; 245:755-762.

5. 5. Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016; 122:1349-1369.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-infiltrating T lymphocytes: A promising immunotherapeutic target for preventing immune escape in cholangiocarcinoma;Biomedicine & Pharmacotherapy;2024-08

2. Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinoma;Biomedicine & Pharmacotherapy;2024-06

3. Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review);International Journal of Oncology;2023-10-27

4. Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis;Cells;2023-08-19

5. Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies;Frontiers in Immunology;2023-04-17